Sharon Bio-Medicine standalone net profit rises 89.03% in the September 2021 quarter

Sales rise 7.88% to Rs 45.19 crore

Net profit of Sharon Bio-Medicine rose 89.03% to Rs 4.48 crore in the quarter ended September 2021 as against Rs 2.37 crore during the previous quarter ended September 2020. Sales rose 7.88% to Rs 45.19 crore in the quarter ended September 2021 as against Rs 41.89 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales45.1941.89 8 OPM %15.1811.10 -PBDT7.305.25 39 PBT4.482.37 89 NP4.482.37 89

Powered by Capital Market - Live News